PB8 fundamentals
An in-depth look to Phibro Animal Health Corp. operating, investing, and financing activities
PB8 free cash flow for Q3 24 is 1.55 M EUR. For 2023, PB8 free cash flow was -35.28 M EUR and operating cash flow was 12.2 M EUR.
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM